Emblica officinalis corrects functional, biochemical and molecular deficits in experimental diabetic neuropathy by targeting the oxido-nitrosative stress mediated inflammatory cascade

Phytotherapy Research

Volumn 25, Issue 10, 2011, Pages 1527-1536

  Tiwari, Vinod ^a   Kuhad, Anurag ^a   Chopra, Kanwaljit ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

allodynia; diabetic neuropathy; Emblica officinalis; interleukin 1beta; transforming growth factor 1; tumor necrosis factor alpha

Indexed keywords

CYTOKINE; EMBLICA OFFICINALIS EXTRACT; INSULIN; INTERLEUKIN 1BETA; NITRITE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG TARGETING; EXPERIMENTAL DIABETES MELLITUS; HYPERALGESIA; HYPERGLYCEMIA; MALE; MOLECULAR BIOLOGY; MONOTHERAPY; NERVE INJURY; NEUROPATHIC PAIN; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PAIN THRESHOLD; RAT; SCIATIC NERVE; TAIL FLICK TEST;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BEHAVIOR, ANIMAL; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERALGESIA; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; NEURALGIA; NITRITES; NITROSATION; OXIDATIVE STRESS; PAIN MEASUREMENT; PAIN THRESHOLD; PHYLLANTHUS EMBLICA; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR; SCIATIC NERVE;

PHYLLANTHUS EMBLICA; RATTUS;

EID: 80053345565     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3440     Document Type: Article

References (59)

1. Ahlgren SC, Levine JD,. 1993. Mechanical hyperalgesia in streptozotocin-diabetic rats. Neuroscience 52: 1049-1055. (Pubitemid 23063547)
2. Anjaneyulu M, Berent-Spillson A, Inoue T, Choi J, Cherian K, Russell JW,. 2008. Transforming growth factor-beta induces cellular injury in experimental diabetic neuropathy. Exp Neurol 211: 469-479.
3. Anjaneyulu M, Chopra K,. 2004. Quercetin attenuates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rats. Indian J Exp Biol 42: 766-769. (Pubitemid 39059184)
4. Apfel SC, Asbury AK, Bril V, Burns TM, Campbell JN, Chalk CH,. 2001. Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials. J Neurol Sci 189: 3-5. (Pubitemid 32776643)
5. Arai K, Maguchi S, Fujii S, Ishibashi H, Oikawa K, Taniguchi N,. 1987. Glycation and inactivation of human Cu-Zn-superoxide dismutase. Identification of the in vitro glycated sites. J Biol Chem 262: 16969-16972. (Pubitemid 18017663)
6. Arora M, Kumar A, Kaundal RK, Sharma SS, 2008. Amelioration of neurological and biochemical deficits by peroxynitrite decomposition catalysts in experimental diabetic neuropathy. Eur J Pharmacol 596: 77-83.
7. 2+ antagonist nimodipine on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats. Brain Res 1035: 86-93. (Pubitemid 40248540)
8. Bolajoko EB, Mossanda KS, Adeniyi F, Akinosun O, Fasanmade A, Moropane M,. 2008. Antioxidant and oxidative stress status in type 2 diabetes and diabetic foot ulcer. S Afr Med J 98: 614-617.
9. Bonnefont-Rousselot D,. 2002. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care 5: 561-568. (Pubitemid 40684653)
10. Calcutt NA, Backonja MM,. 2007. Pathogenesis of pain in peripheral diabetic neuropathy. Curr Diab Rep 7: 429-434. (Pubitemid 350284973)
11. Calcutt NA, Chaplan SR,. 1997. Spinal pharmacology of tactile allodynia in diabetic rats. Br J Pharmacol 122: 1478-1482. (Pubitemid 27503941)
12. Calcutt NA, Jorge MC, Yaksh TL, Chaplan SR,. 1996. Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine. Pain 68: 293-299. (Pubitemid 27025887)
13. Cameron NE, Cotter MA,. 1999. Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Res Clin Pract 45: 137-146. (Pubitemid 29457761)
14. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL,. 1994. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53: 55-63. (Pubitemid 24238751)
15. Courteix C, Eschalier A, Lavarenne J,. 1993. Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain 53: 81-88. (Pubitemid 23137271)
16. Cui XP, Li BY, Gao HQ, Wei N, Wang WL, Lu M,. 2008. Effects of grape seed proanthocyanidin extracts on peripheral nerves in streptozotocin-induced diabetic rats. J Nutr Sci Vitaminol (Tokyo) 54: 321-328.
17. Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH,. 1992. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 107: 660-664.
18. DCCT, 1993. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986.
19. Drel VR, Pacher P, Vareniuk I, et al,. 2007. Evaluation of the peroxynitrite decomposition catalyst Fe(III) tetra-mesitylporphyrin octasulfonate on peripheral neuropathy in a mouse model of type 1 diabetes. Int J Mol Med 20: 783-792.
20. Evans JL, Goldfine ID, Maddux BA, Grodsky GM,. 2002. Oxidative stress and stressactivated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23: 599-622. (Pubitemid 35191625)
21. Ghosal S, Tripathi VK, Chauhan S,. 1996. Active constituents of Emblica officinalis. Part I. The chemistry and antioxidative effects of two new hydrolysable tannins, emblicanin A and B. Indian J Chem Sec B 35: 941-948. (Pubitemid 126463354)
22. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR,. 1982. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126: 131-138. (Pubitemid 13203451)
23. Gul H, Yildiz O, Dogrul A, Yesilyurt O, Isimer A,. 2000. The interaction between IL-1beta and morphine: possible mechanism of the deficiency of morphine-induced analgesia in diabetic mice. Pain 89: 39-45.
24. Guneli E, Kazikdas KC, Kolatan E,. 2007. Ghrelin may attenuate proinflammatory cytokine-mediated neuropathic pain. Med Hypotheses 69: 356-360. (Pubitemid 46818717)
25. Halliwell B,. 1991. Drug antioxidant effects. A basis for drug selection? Drugs 42: 569-605. (Pubitemid 21920775)
26. Hounsom L, Tomlinson DR,. 1997. Does neuropathy develop in animal models? Clin Neurosci 4: 380-389. (Pubitemid 27465452)
27. Ito T, Ohtori S, Hata K, et al,. 2007. Rho kinase inhibitor improves motor dysfunction and hypoalgesia in a rat model of lumbar spinal canal stenosis. Spine (Phila Pa 1976) 32: 2070-2075. (Pubitemid 47359612)
28. Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR,. 1974. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzenoxide as the hepatotoxic intermediate. Pharmacology 11: 151-169.
29. Julius U, Drel VR, Grassler J, Obrosova IG,. 2009. Nitrosylated proteins in monocytes as a new marker of oxidative-nitrosative stress in diabetic subjects with macroangiopathy. Exp Clin Endocrinol Diabetes 117: 72-77.
30. Kamboj SS, Chopra K, Sandhir R,. 2008. Neuroprotective effect of N-acetylcysteine in the development of diabetic encephalopathy in streptozotocin-induced diabetes. Metab Brain Dis 23: 427-443.
31. Kamei J, Mizoguchi H, Narita M, Tseng LF,. 2001. Therapeutic potential of PKC inhibitors in painful diabetic neuropathy. Expert Opin Investig Drugs 10: 1653-1664. (Pubitemid 32827426)
32. Kannan SA, Saade NE, Haddad JJ, Abdelnoor AM, Atweh SF, Jabbur SJ,. 1996. Endotoxin induced local inflammation and hyperalgesia in rats mince, a new model for inflammatory pain. Pain 66: 373-379. (Pubitemid 26284008)
33. Kim SY, Lee JH, Yang ES, Kil IS, Park JW,. 2003. Human sensitive to apoptosis gene protein inhibits peroxynitrite-induced DNA damage. Biochem Biophys Res Commun 301: 671-674. (Pubitemid 36268943)
34. Kono Y,. 1978. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 186: 189-195. (Pubitemid 8290500)
35. Konrad RJ, Mikolaenko I, Tolar JF, Liu K, Kudlow JE,. 2001. The potential mechanism of the diabetogenic action of streptozotocin: inhibition of pancreatic beta-cell O-GlcNAc-selective N-acetyl-beta-D-glucosaminidase. Biochem J 356 (P1): 31-41. (Pubitemid 34275703)
36. Kuhad A, Chopra K,. 2009. Tocotrienol attenuates oxidative-nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy. Neuropharmacology 57: 456-462.
37. Kuzumoto Y, Kusunoki S, Kato N, Kihara M, Low PA,. 2006. Effect of the aldose reductase inhibitor fidarestat on experimentaldiabetic neuropathy in the rat. Diabetologia 49: 3085-3093. (Pubitemid 44730313)
38. Love A, Cotter MA, Cameron NE,. 1996. Effects of the sulphydryl donor N-acetyl-L-cysteine on nerve conduction, perfusion, maturation and regeneration following freeze damage in diabetic rats. Eur J Clin Invest 26: 698-706. (Pubitemid 26273720)
39. Low PA, Nickander KK, Tritschler HJ,. 1997. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 46 (S2): S38-S42. (Pubitemid 27377396)
40. Nickander KK, McPhee BR, Low PA, Tritschler H,. 1996. Alpha-lipoic acid: antioxidant potency against lipid peroxidation of neural tissues in vitro and implications for diabetic neuropathy. Free Radic Biol Med 21: 631-639. (Pubitemid 26331093)
41. Obrosova IG, Drel VR, Pacher P, et al,. 2005. Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. Diabetes 54: 3435-3441. (Pubitemid 43334333)
42. Pirart J,. 1977. Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973 (3rd and last part) (author's transl). Diabetes Metab 3: 245-256. (Pubitemid 8236012)
43. Pop-Busui R, Marinescu V, Van Huysen C, et al,. 2002. Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl- l -carnitine administration. Diabetes 51: 2619-2628. (Pubitemid 34827415)
44. Sagara M, Satoh J, Zhu XP, et al,. 1994. Inhibition with N-acetylcysteine of enhanced production of tumor necrosis factor in streptozotocininduced diabetic rats. Clin Immunol Immunopathol 71: 333-337.
45. Satoh J, Yagihashi S, Toyota T,. 2003. The possible role of tumor necrosis factor-alpha in diabetic polyneuropathy. Exp Diabesity Res 4: 65-71. (Pubitemid 37080774)
46. Sima AA,. 2006. Pathological mechanisms involved in diabetic neuropathy: can we slow the process? Curr Opin Investig Drugs 7: 324-337.
47. Suryanarayana P, Saraswat M, Petrash JM, Reddy GB,. 2007. Emblica officinalis and its enriched tannoids delay streptozotocin induceddiabetic cataract in rats. Mol Vis 13: 1291-1297. (Pubitemid 47128953)
48. Taiwo YO, Coderre TJ, Levine JD,. 1989. The contribution of training to sensitivity in the nociceptive paw-withdrawal test. Brain Res 487: 148-151. (Pubitemid 19135176)
49. Tiwari V, Kuhad A, Chopra K,. 2009. Tocotrienol ameliorates behavioral and biochemical alterations in the rat model of alcoholic neuropathy. Pain 145 (1-2): 129-135.
50. van Dam PS,. 2002. Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives. Diabetes Metab Res Rev 18: 176-184.
51. Vani T, Rajani M, Sarkar S, Shishoo CJ,. 1997. Antioxidant property of the Ayurvedic formulation Triphala and its constituents. Int J Pharmacol 35: 313-317.
52. Viggiano A, Monda M, Viggiano D, et al,. 2005. Trigeminal pain transmission requires reactive oxygen species production. Brain Res 1050: 72-78. (Pubitemid 40922719)
53. Vincent AM, Russell JW, Low P, Feldman EL,. 2004. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev 25: 612-628. (Pubitemid 39096072)
54. Wagner R, Myers RR,. 1996. Endoneural injection of TNF-alpha produces neuropathic pain behaviors. Neuroreport 7: 2897-2901. (Pubitemid 26426355)
55. Wild S, Roglic G, Green A, Sicree R, King H,. 2004. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053. (Pubitemid 38579764)
56. Wills ED,. 1965. Mechanism of lipid peroxide formation in animals. Biochem J 99: 667-676.
57. Wu S, Ren J,. 2006. Benfotiamine alleviates diabetes-induced cerebral oxidative damage independent of advanced glycation end-product, tissue factor and TNF-alpha. Neurosci Lett 394: 158-162. (Pubitemid 43061479)
58. Ziegler D,. 2008. Treatment of diabetic neuropathy and neuropathic pain: how far have we come? Diabetes Care 31 (Suppl2): S255-S261.
59. Zochodne DW, Levy D,. 2005. Nitric oxide in damage, disease and repair of the peripheral nervous system. Cell Mol Biol (Noisy-le-grand) 51: 255-267. (Pubitemid 43093377)